Nitin Patel

University of MissouriUnited States of America

NITIN C. PATEL, M.D., MPH PROFESSOR DEPARTMENT OF CHILD HEALTH DIVISION OF PEDIATRIC NEUROLOGY UNIVERSITY OF MISSOURI HEALTH CARE Dr. Nitin Patel earned his medical degree from Jabalpur University Government Medical College in Jabalpur, India. Following the completion of an externship in pediatrics at St. John=s Hospital in Brooklyn, New York, Dr. Patel completed his residency in pediatrics at the New York Medical College, Lincoln Program, in the Bronx, New York. He was awarded two fellowships. His first fellowship was in pediatric neurology and his second in epileptology: both were completed an UMDNJ-New Jersey Medical School Program in Newark. He currently serves as a professor at the University of Missouri Hospital and clinic, Department of Child Health in Columbia, MO. Dr. Patel is board certified in neurology and in pediatrics. Dr. Patel provides neurologic testing and treatment for cephalic disorder, ADHD, cerebral palsy, headaches, migraines, movement disorders, and tumors. He specializes in pediatric neurology, epilepsy and neuro metabolic disorders. Dr. Patel provides extensive experience, compassion, and the latest technology in addressing neurological concerns for the patient and their family. Dr. Patel speaks English, Hindi, and Gujarati. He has co-authored Case of the Month, ADejerine-Sottas Neuropathy in Mother and Son with Same Point Mutation of PMP22\ published in Gene, Muscle, and Nerve, AA Double-Blind, Randomized Trial of Topiramate as Adjunctive Therapy for Partial-Onset Seizures in Children@, Neurology, ACentral Hyperventilation Related to Administration of Topiramate@, Ped Neuro and ANeonatal Injuries in Child Abuse@, 238.htm, Peripheral Neurophysiology of acute distal spinal cord infarction, Pediatric Neurology, Childhood-onset multiple sclerosis and mood disorders: a case study, Child Neuropsychology, and The use of levetiracetam in refractory status epilepticus, Seizure-European Journal of Epilepsy. He has worked on several research studies including Gabapentin Treatment for Partial Complex Seizures in Children, Long-Term Study to Assess the Safety of Lamictal in Pediatric Subjects, Behavioral Changes Associated with Lamotrigine and Levetiracetam in Patients with Epilepsy, A Randomized, Double-Blind, Placebo Controlled, Fixed Dose-ranging Study to Assess the Safety, Tolerability and Efficacy of Topiramate as Adjunctive Therapy for Infants with Refractory Partial and Clinically Generalized Epilepsy, A Randomized, Open-Label, Multicenter Study With Open-Label Extension of the Pharmokinetics and Safety of Topiramate Administered as the Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy in Therapy in Infants (Aged 1 to 23 months) With Refractory Partial-Onset Seizures and Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5 mg in the Treatment of Migraine in Adolescents.

2chapters authored